Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants

J Antimicrob Chemother. 2022 Nov 28;77(12):3524. doi: 10.1093/jac/dkac305.

Author

Joseph F Standing^{1

2}

Affiliations

¹ Infection, Immunity and Inflammation, Great Ormond Street Institute of Child Health, University College London, London, UK.
² Pharmacy Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Bacterial Infections*
Humans
Infant
Infant, Newborn
Kinetics
Mezlocillin* / administration & dosage
Mezlocillin* / pharmacokinetics

Substances

Mezlocillin